Northwest & Ethical Investments L.P. Vertex Pharmaceuticals Inc Transaction History
Northwest & Ethical Investments L.P.
- $3.68 Trillion
- Q4 2024
A detailed history of Northwest & Ethical Investments L.P. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 27,822 shares of VRTX stock, worth $12.7 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
27,822
Previous 26,640
4.44%
Holding current value
$12.7 Million
Previous $12.4 Billion
9.57%
% of portfolio
0.3%
Previous 0.33%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,717Shares Held
223MCall Options Held
1.64MPut Options Held
1.37M-
Capital World Investors Los Angeles, CA26.8MShares$12.2 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.6 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.7 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.38 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.1 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $117B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...